Soft Tissue Sarcomas clinical trials

Explore recruiting soft tissue sarcomas clinical trials.

Recruiting soft tissue sarcomas studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Soft Tissue Sarcomas trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TARSARC : TARGETING ATR IN SOFT-TISSUE SARCOMAS: A RANDOMIZED PHASE II STUDY

France

Therapeutic exploratory (Phase II) EU CTIS Study details

MULTISARC : MOLECULAR PROFILING OF ADVANCED SOFT-TISSUE SARCOMAS. A phase III study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas.

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase II, Single-arm Clinical Trial Evaluating Efficacy and Safety of Pembrolizumab in Combination With a Soluble LAG-3 Protein, Eftilagimod Alpha, and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcomas (EFTISARC-NEO)

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Soft Tissue Sarcomas trials by city

Soft Tissue Sarcomas clinical trials

Recruiting soft tissue sarcomas studies right now

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

AB122 Platform Study

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors

Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Also recruiting in Europe

TARSARC : TARGETING ATR IN SOFT-TISSUE SARCOMAS: A RANDOMIZED PHASE II STUDY

MULTISARC : MOLECULAR PROFILING OF ADVANCED SOFT-TISSUE SARCOMAS. A phase III study

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas.

Phase II, Single-arm Clinical Trial Evaluating Efficacy and Safety of Pembrolizumab in Combination With a Soluble LAG-3 Protein, Eftilagimod Alpha, and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcomas (EFTISARC-NEO)

Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas

Soft Tissue Sarcomas trials by city

Other conditions